IMM 1.69% 30.0¢ immutep limited

one poster's well researched opinion, page-40

  1. 701 Posts.


    Looks to me like CANVAS is a stage 3 trial with a phase 2 placebo study.
    This is not a delay as the endpoint of the phase 3 is still set for 2015.

    ""Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy (CANVAS)
    This study is currently recruiting participants.
    Verified March 2012 by Prima BioMed Ltd


    Condition - Epithelial Ovarian Cancer

    Intervention / Phase
    -----------------------------------
    Biological: Placebo Study Agent / Phase II
    Biological: Cvac / Phase III
    ""

    ""Estimated Study Completion Date: December 2015
    Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)""


 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.005(1.69%)
Mkt cap ! $436.3M
Open High Low Value Volume
29.5¢ 31.0¢ 29.0¢ $504.5K 1.673M

Buyers (Bids)

No. Vol. Price($)
2 39998 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 3997 1
View Market Depth
Last trade - 16.10pm 28/10/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.